Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer Therapy
Primary chemotherapy and debulking surgery advised for ovarian cancer management
November 10th, 2005
Researchers endorsed the use of primary chemotherapy and adjuvant tumor debulking in the management of advanced-stage epithelial ovarian cancer. According to recent research published in the International Journal of Gynecological Cancer, "The aim of this article was to review the experience with neoadjuvant chemotherapy and interval surgical debulking in patients with metastatic epithelial ovarian cancer. A retrospective chart review was carried out to identify patients treated with neoadjuvant platinum/Taxol chemotherapy and interval debulking." "Cox regression modeling was used to identify significant predictors of progression-free interval....
Source: Women's Health Weekly (2005-11-10)
|
